NCT05926011View on ClinicalTrials.gov

Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease

NARecruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

July 24, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Alzheimer Disease
Interventions
DEVICE

RGn600

RGn600 with a 10 Hz-pulsed wave mode light emission

DEVICE

RGn600 Sham

RGn600 inactivated

Trial Locations (6)

13005

NOT_YET_RECRUITING

Hôpital de la Timone,, Timone

75010

NOT_YET_RECRUITING

Hôpital Lariboisière, Paris

75013

NOT_YET_RECRUITING

Hôpital Broca, Paris

81100

RECRUITING

CHIC Castres Mazamet Site Autan, Castres

81500

RECRUITING

CH Lavaur, Lavaur

31 000

RECRUITING

Toulouse University Hospital Gerontopole, Toulouse

All Listed Sponsors
collaborator

RCTs

INDUSTRY

collaborator

University Hospital, Toulouse

OTHER

lead

REGEnLIFE SAS

INDUSTRY